Phio Pharmaceuticals(PHIO)
$0.810.00 (0.00%)
PHIO
Phio Pharmaceuticals financials statements
$0.81
At close:0.00 (0.00%)
Want to see PHIO full AI Analyst Report?
Phio Pharmaceuticals (PHIO) Ratios
666 Followers
Phio Pharmaceuticals Ratios
PHIO's free cash flow for Q3 2026 was $-2.28M. For the 2026 fiscal year, PHIO's free cash flow was increased by $0.00 and operating cash flow was $-2.28M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 49.37 | 5.65 | 5.71 | 6.42 | 8.06 |
| Quick Ratio | 49.37 | 5.65 | 5.71 | 6.42 | 8.06 |
| Cash Ratio | 48.35 | 5.30 | 5.20 | 6.08 | 7.84 |
| Solvency Ratio | -6.49 | -7.04 | -6.51 | -5.78 | -4.08 |
| Operating Cash Flow Ratio | -18.34 | -7.01 | -6.58 | -6.26 | -3.87 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 20.14M | $ 4.72M | $ 7.69M | $ 10.47M | $ 21.49M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.07 | 1.21 | 1.21 | 1.18 | 1.15 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.15 | 1.35 | 2.49 |
| Net Debt to EBITDA | 2.42 | 0.75 | 0.79 | 1.02 | 1.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 94.34% | 96.79% | 100.02% | 100.16% | 98.34% |
| Return on Assets (ROA) | -40.48% | -124.61% | -115.61% | -89.59% | -52.79% |
| Return on Equity (ROE) | -43.17% | -151.39% | -140.05% | -105.90% | -60.58% |
| Return on Capital Employed (ROCE) | -43.80% | -156.40% | -140.03% | -105.40% | -61.13% |
| Return on Invested Capital (ROIC) | -43.80% | -156.40% | -139.39% | -104.11% | -60.79% |
| Return on Tangible Assets | -40.48% | -124.61% | -115.61% | -89.59% | -52.79% |
| Earnings Yield | -138.43% | -504.43% | -685.17% | -226.47% | -103.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 10.62 | 14.40 | 9.64 | 9.00 | 31.40 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -34.38 | -25.35 | -37.87 | -40.55 | -11.62 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 34.38 | 25.35 | 37.87 | 40.55 | 11.62 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.33 | -9.03 | -46.53 | -96.14 | -99.91 |
| Free Cash Flow Per Share | -1.34 | -9.03 | -46.55 | -97.10 | -100.34 |
| Dividend Paid and CapEx Coverage Ratio | -664.92 | -7112.00 | -2149.80 | -100.24 | -232.51 |
| Capital Expenditure Coverage Ratio | -664.92 | -7112.00 | -2149.80 | -100.24 | -232.51 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -307.11 | -71.35 | -40.20 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -127.18% | -501.82% | -680.62% | -241.66% | -92.91% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.72 | -1.98 | -0.15 | -0.44 | -0.96 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.31 | 0.30 | 0.20 | 0.47 | 0.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.79 | -0.20 | -0.15 | -0.41 | -1.08 |
| Price-to-Operating Cash Flow Ratio | -0.79 | -0.20 | -0.15 | -0.42 | -1.08 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.02 | 0.00 | 0.02 | 0.02 |
| Enterprise Value Multiple | 1.70 | 0.55 | 0.65 | 0.57 | 0.81 |
| Enterprise Value | -14.75M | -3.96M | -6.87M | -6.54M | -10.94M |
| EV to EBITDA | 1.70 | 0.55 | 0.65 | 0.57 | 0.81 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 1.85 | 0.56 | 0.64 | 0.53 | 0.92 |
| EV to Operating Cash Flow | 1.85 | 0.56 | 0.64 | 0.54 | 0.92 |
| Tangible Book Value Per Share | 3.37 | 6.00 | 33.46 | 85.92 | 184.79 |
| Shareholders’ Equity Per Share | 3.37 | 6.00 | 33.46 | 85.92 | 184.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.45 | -9.08 | -46.87 | -91.00 | -111.95 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.92 | 0.99 | 0.99 | 1.06 | 0.89 |
Currency in USD
